Attenuated renovascular constrictor responses to angiotensin II in adenosine 1 receptor knockout mice.
In the present experiments we examined the renovascular constrictor effects of ANG II in the chronic and complete absence of A1 adenosine receptors (A1AR) using mice with targeted deletion of the A1AR gene. Glomerular filtration rate (GFR) was not different between A1AR +/+ and A1AR -/- mice under control conditions (450.5 +/- 60 vs. 475.2 +/- 62.5 microl/min) but fell significantly less in A1AR -/- mice during infusion of ANG II at 1.5 ng/min (A1AR +/+: 242 +/- 32.5 microl/min, A1AR -/-: 371 +/- 42 microl/min; P = 0.03). Bolus injection of 1, 10, and 100 ng of ANG II reduced renal blood flow and increased renal vascular resistance significantly more in A1AR +/+ than in A1AR -/- mice. Perfused afferent arterioles isolated from A1AR +/+ mice constricted in response to bath ANG II with an EC50 of 1.5 +/- 0.4 x 10(-10) mol/l, whereas a right shift in the dose-response relationship with an EC50 of 7.3 +/- 1.2 x 10(-10) mol/l (P < 0.05) was obtained in arterioles from A1AR -/- mice (P < 0.05). The expression of AT1A receptor mRNA was not different in kidney RNA from A1AR +/+ or A1AR -/- mice. We conclude that chronic A1AR deficiency diminishes the effectiveness of ANG II to constrict renal resistance vessels and to reduce GFR.
Hansen
Pernille B
PB
NIDDK, NIH, Bldg. 10, Rm. 4 D51, 10 Center Dr. MSC 1370, Bethesda, MD, USA.
Hashimoto
Seiji
S
Briggs
Josie
J
Schnermann
Jurgen
J
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001160:Arterioles / Q000502:physiology; D001794:Blood Pressure / Q000502:physiology; D005260:Female; D015870:Gene Expression / Q000502:physiology; D005919:Glomerular Filtration Rate / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D044140:Receptor, Angiotensin, Type 1; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics*; D011945:Receptors, Angiotensin / Q000235:genetics; D012079:Renal Circulation / Q000187:drug effects* / Q000502:physiology*; D014655:Vascular Resistance / Q000502:physiology; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D044140:Receptor, Angiotensin, Type 1; D018340:Receptors, Adrenergic, alpha-1; D011945:Receptors, Angiotensin; D014662:Vasoconstrictor Agents; D000804:Angiotensin II